Furthermore, our data suggest that these responsive eosinophils are already baseline activated (high CD11b expression, lowered CD62L expression) during the COVID-19 infection, supporting the concept that eosinophils play a role in the pathogenesis of (mild) COVID-19. This evidence concerns the gene ITGAM and COVID-19.